Immunology and Microbiology
Immunosuppressive Drug
100%
Cancer Cell
100%
Cell Metabolism
100%
Myeloid-Derived Suppressor Cell
100%
Carcinoma Cell
60%
Fatty Acid Metabolism
60%
Immunocompetent Cell
40%
Tumor Cell
40%
Secretion (Process)
40%
Cytokine
20%
Energy Metabolism
20%
Aerobic Glycolysis
20%
Immune Response
20%
RNA Sequencing
20%
Immune System
20%
Cell Shape
20%
Oxygen Consumption
20%
Hepatocellular Carcinoma Cell Line
20%
Energy Yield
20%
Gene Inactivation
20%
MAPK Signaling
20%
Complement Component 3
20%
Keyphrases
Immunosuppressive Microenvironment
100%
Hepatocellular Carcinoma
100%
Cancer Cell Metabolism
100%
PIWIL1
100%
Myeloid-derived Suppressor Cells
38%
Hepatocellular Carcinoma Cells
30%
Overexpressing
23%
Immune Response
23%
Fatty Acid Metabolism
23%
Tumor Microenvironment
15%
Tumor Cells
15%
Tumor
15%
Interleukin-10
15%
Opposite Effects
7%
Energy Production
7%
Immunosuppressive Cytokines
7%
Knockdown
7%
Overexpression
7%
Tumor Progression
7%
Energy Metabolism
7%
Immunosuppressive Activity
7%
Immune Regulation
7%
Aerobic Glycolysis
7%
RNA-seq Analysis
7%
Cell Shape
7%
Microenvironment
7%
P38 MAPK Pathway
7%
Human Hepatocellular Carcinoma
7%
Oxygen Consumption
7%
Proliferation Rate
7%
Metabolic Response
7%
In Vitro Proliferation
7%
PIWI-interacting RNA (piRNA)
7%
In Vivo Growth
7%
Hepatocellular Carcinoma Treatment
7%
Hepatic Tissue
7%
Complement C3
7%
RNA-mediated Gene Silencing
7%
Cell Depletion
7%
Biochemistry, Genetics and Molecular Biology
Myeloid
100%
Cancer Cell
100%
Cell Metabolism
100%
Fatty Acid Metabolism
60%
Secretion (Process)
40%
Immunocompetent Cell
40%
Immunity
20%
Oxygen Consumption
20%
Energy Metabolism
20%
RNA Sequencing
20%
RNA
20%
Aerobic Glycolysis
20%
Tumor Progression
20%
Immune Response
20%
Cell Shape
20%
Energy Yield
20%
Cytokine
20%
Gene Inactivation
20%
P38 Mitogen-Activated Protein Kinases
20%
MAPK Signaling
20%
Complement Component 3
20%
Piwi
20%